Search Results - "Cruz, C Russell Y"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function by Sweeney, Elizabeth E., Balakrishnan, Preethi B., Powell, Allison B., Bowen, Allan, Sarabia, Indra, Burga, Rachel A., Jones, R. Brad, Bosque, Alberto, Cruz, C. Russell Y., Fernandes, Rohan

    Published in Nano research (01-03-2020)
    “…Natural killer (NK) cells are attractive effector cells of the innate immune system against human immunodeficiency virus (HIV) and cancer. However, NK cell…”
    Get full text
    Journal Article
  3. 3

    Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma by Burga, Rachel A, Yvon, Eric, Chorvinsky, Elizabeth, Fernandes, Rohan, Cruz, C Russell Y, Bollard, Catherine M

    Published in Clinical cancer research (15-07-2019)
    “…The ability of natural killer (NK) cells to lyse allogeneic targets, without the need for explicit matching or priming, makes them an attractive platform for…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles by Sweeney, Elizabeth E, Sekhri, Palak, Telaraja, Deepti, Chen, Jie, Chin, Samantha J, Chiappinelli, Katherine B, Sanchez, Carlos E, Bollard, Catherine M, Cruz, C Russell Y, Fernandes, Rohan

    Published in Cytotherapy (Oxford, England) (01-07-2023)
    “…Adoptive T cell therapy (ATCT) has been successful in treating hematological malignancies and is currently under investigation for solid-tumor therapy. In…”
    Get full text
    Journal Article
  6. 6

    Generating suppression-resistant natural killer cells as an enhanced immunotherapeutic for neuroblastoma by Burga, Rachel A., Williams, Elizabeth, Yvon, Eric, Fernandes, Rohan, Cruz, C. Russell Y., Bollard, Catherine M.

    Published in The Journal of immunology (1950) (01-05-2018)
    “…Abstract Refractory neuroblastoma (NB) has a poor prognosis and there is a need to explore novel therapies. Natural killer (NK) cells serve as a promising…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10